Dr. Donald Kohn has been awarded a $14.7 million grant from the California Institute for Regenerative Medicine to develop a commercial manufacturing protocol for a groundbreaking gene therapy targeting ADA-SCID, a rare and life-threatening immune disorder.
https://www.uclahealth.org/news/release/donald-kohn-awarded-147m-cirm-grant-advance-ada-scid-gene